Huma wins 'pharma's Nobel prize', the Prix Galien USA award. Learn more 
hospital at home
Helping clinical teams create 'hospital at home' services for an episode of care with a specific time frame. This prevents unnecessary admissions and readmissions, cancellations and supports discharge and rehabilitation.
Our 'hospital at home' provides care throughout the perioperative pathway.
Patients are prepared for their surgery using timely educational content, questionnaires, symptom and activity tracking, alongside telemedicine.
After surgery patients are monitored remotely to guide their rehabilitation. Clinical teams gather aggregated, anonymised data to study and learn from the outcomes of surgery for each type of implant, surgical technique and approach to rehabilitation.
"The app is a major development which we believe will make an immediate impact on the surgical landscape."
Reduction in
length of stay
of respondents said
the Huma app was
easy to use1
Reduction in
unnecessary
readmissions
We are working with clinicians at Royal Brompton and Harefield hospitals to help clinicians safely and efficiently manage patients who are waiting for surgery. Our technology is just one way the clinical teams are working with their patients, but it gives them greater ability to remotely monitor patients and identify any who need further intervention.
Patients successfully onboarded2
of patients identified as
at-risk of deterioration
and escalated3
of patients highlighted as
deteriorating had operation
dates brought forward3
Huma is currently working with Bayer, Stanford Medicine and the Stanford Center for Digital Health (CDH) to validate an approach to decentralize the clinical trial experience for patient participants with atrial fibrillation. The study aims to prove the feasibility, acceptability, and best practices that can achieve high compliance, quality, and scientifically sound fully remote clinical trials.
94% of participants
recruited in 12 days4
Increased oral anticoagulation adherence from 85% to 96% in patients with low baseline adherence4
Participant
retention4
Huma’s ‘hospital at home’ service for COVID-19 allows clinicians to remotely monitor their patients via their smartphones.
Our technology has shown to almost double clinical capacity, reduce readmissions, improve patient experience, and save money. Operating at a national-level across England, Germany and the UAE.
"I got all the monitoring of a hospital ward, right here at home."
can reduce readmission
rate by >30%1
can almost double
clinical capacity1
of patients reported ‘good’
or ‘very good’ care1
90% reported the app as
‘good’ or ‘very good’1
personalised care
news
LinkedIn rates Medopad as one of the 25 most sought after startups to work for in the UK
1. nhsx.nhs.uk/covid-19-response/technology-nhs/huma-medopad-evaluation-remote-digital-care-platform/
The full report is available on request. Patient feedback based on sample size of 30 responses.
2. Data correct as of October 2021.
3. Obika, BD et al. (2021) Implementation of a mHealth solution to remotely monitor patients on a cardiac surgical waiting list: service evaluation (2021) JAMIA Open 4(3) doi.org/10.1093/jamiaopen/ooab053
4. Data from 2021 single-arm, six-month study. Paper in submission.
5. Huma is committed to respecting your privacy, and we’ll only use your personal details to send you the Huma Healthcare Guide. You can review our Privacy Policy for further information.